Skip to main content

Summary Judgment For J&J's Mentor TVM Reversed

Summary Judgment For J&J's Mentor TVM Reversed

Summary Judgment For J&J's Mentor TVM Reversed

Introduction

A three-judge panel in the 11th U.S. Circuit Court of Appeals reversed the summary judgment granted to a plaintiff in a case against Johnson & Johnson unit Mentor Worldwide LLC over the alleged complications related to the company's defective ObTape Transobturator Sling. The appeals court opined that the case can head to trial, despite being late-filed contradicting the trial court's earlier findings.

The Florida resident filed her complaint seven years after the transvaginal mesh (TVM) was removed when she came across a plaintiff lawyer's advertisement. Until then she was not alerted about the potential claims against the manufacturer. While the company stands by the device's efficiency and safety, the sling was removed from the market in 2006. Cases against Mentor continue to be filed by women facing complications as the mesh gets too ingrained in the vaginal tissues to be removed safely. The company settled a handful of cases back in September and October of 2014. J&J agreed on settling Mentor TVM cases for 111 plaintiffs for an undisclosed amount in the U.S. District Court for the Middle District of Georgia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!